The basis of the discovery process for a new pharmaceutical product
| Autor: | Veselin Dickov |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2012 |
| Předmět: |
Active ingredient
Value (ethics) business.industry Pharmacy the cost of pharmaceutical products General Medicine pricing regulations Pharmacology pharmaceutical market Business process discovery Medicine Pharmaceutical engineering new drug development Product (category theory) Marketing business Organism Pharmaceutical industry |
| Zdroj: | Open Medicine, Vol 7, Iss 6, Pp 691-699 (2012) |
| ISSN: | 2391-5463 |
| Popis: | The basis of the discovery process for a new pharmaceutical product is in understanding the mechanism of action of a particular disease or processes in the organism related to the disease and/or its symptoms. The essence of a pharmaceutical is in the active ingredient capable of affecting processes within the organism beneficially. The discovery process includes a particular sequence of activities of various profiles of experts, about which various authors agree. The history of pharmaceutical industry (and pharmacy) is measured from one discovery of an innovative drug or approach to treatment of a particular disease to the next one. The cost of pharmaceutical products is one of the key causes of controversy related to this industry. Numerous cultures have proverbs expressing the opinion that health is priceless or that health is the greatest wealth. What if health does have a price? One of the basic premises of marketing is that price should reflect consumer value. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|